The president of URPLiPB has published information on recommendations issued by the EC, HMA and EMA on measures to avoid shortages of key antibiotics for treating respiratory tract infections during the upcoming winter season.
If demand in the upcoming winter season is similar to the average level of consumption in previous years, the data collected suggests that the EU supply of oral formulations covering key first- and second-line antibiotics for the treatment of respiratory tract infections will match demand in the upcoming winter season. The EMA and the European Health Emergency Preparedness and Response Authority (HERA) will continue to work with responsible part...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
